Fat and carbohydrate are the major fuel sources utilised for oxidative, mitochondrial 25 adenosine triphosphate (ATP) resynthesis during human skeletal muscle contraction. 26
Introduction 45
Carbohydrate and fat are the primary fuel sources for mitochondrial ATP resynthesis 46 in human skeletal muscle. The relative utilisation of these two substrates duringexercise can vary substantially and depends strongly on substrate availability and 48 exercise duration and intensity. Fat constitutes the largest energy reserve in the body 49 and in terms of the amount available it is not limiting to endurance exercise 50 performance. However, fat exhibits a relatively low maximal rate of oxidation in vivo, 51 which begins to measurably decline at an exercise intensity of around 60 to 70% of 52 maximal oxygen consumption (VO2max), above which muscle glycogen becomes the 53 major fuel supporting ATP resynthesis (1, 2, 3) . The muscle glycogen stores are limited 54 and it has been well established that muscle glycogen depletion coincides with fatigue 55 during very prolonged high intensity endurance exercise (4) . As fatigue can be 56 postponed by increasing pre-exercise muscle glycogen content (4) , it is thought that 57 augmenting the rate of fat oxidation during endurance exercise could delay glycogen 58 depletion and improve prolonged endurance exercise performance. Indeed, it has long 59 been known that enhanced fat oxidation is one of the main muscle adaptations to 60 endurance exercise training (5) . However, the mechanisms that regulate the relative 61 contributions of carbohydrate and fat oxidation in skeletal muscle during exercise 62
have not been clearly elucidated. Several potential regulatory points (Figure 1) could 63 influence the decline in the rate of fat oxidation in skeletal muscle during high 64 intensity endurance exercise, including: 1) regulation of lipolysis within adipose 65 tissue and intramuscular triacylglycerol (IMTG) pools; 2) transport and delivery of 66 circulating free fatty acids from adipose tissue stores to working skeletal muscle; 3) 67 transport of fatty acids across the muscle cell membrane and within the cell cytosol to 68 the outer mitochondrial membrane; 4) transport of fatty acid across the outer 69 mitochondrial membrane via carnitine palmitoyltransferase 1 (CPT1), the rate 70 limiting step in fatty acid oxidation, and 5) intramitochondrial enzymatic reactions 71 distal to CPT1. The present review will primarily address the theory that a 72 carbohydrate flux mediated reduction in the availability of muscle carnitine, the major 73 substrate for CPT1, is a key mechanism for the decline in fat oxidation during high 74 intensity exercise. This is discussed in relation to recent work in this area taking 75 advantage of the discovery that skeletal muscle carnitine content can be nutritionally 76 increased in vivo in humans and have a significant impact upon fuel selection during 77 endurance exercise. 
Integration of fat and carbohydrate oxidation during exercise 82
There is increasing evidence to suggest that fat oxidation during exercise is directly 83 regulated by the rate of flux though the mitochondrial pyruvate dehydrogenase 84 enzyme complex (PDC), a rate limiting step in skeletal muscle carbohydrate 85 oxidation. Increasing exercise intensity, from moderate to high, or increasing 86 carbohydrate availability during exercise, increases glycolysis and flux through the 87 PDC with a corresponding decrease in the rate of fat oxidation (1, 2, 6) . A likely site of 88 the regulation of fat oxidation by carbohydrate flux is CPT1. Increasing glucose 89 availability at rest, via a hyperglycaemic-hyperinsulinaemic clamp, decreases long-90 chain fatty acid ([ 13 C]oleate) oxidation with no effect on medium-chain fatty acid 91
. This would suggest an inhibition of fat oxidation at the 92 level of CPT1 as medium-chain fatty acids cross the mitochondrial membrane to be 93 oxidized independently of CPT1. The same effect of carbohydrate was seen during 94 moderate intensity exercise at 50% VO2max, where hyperglycaemia (induced as a 95 result of pre-exercise ingestion of glucose) increased glycolytic flux and reduced 96 long-chain fatty acid ([1-
13 C]palmitate) oxidation (8) . Again, medium-chain [1-97
13 C]octanoate oxidation was unaffected, suggesting that carbohydrate metabolism can 98 also directly limit fat oxidation at the level of CPT1 during exercise. It should be 99 noted that these responses might have been mediated, at least in part, via an insulin-100 induced inhibition of adipose tissue lipolysis, resulting in decreased plasma free fatty 101 acid (FFA) availability. However, in the study of Sidossis and Wolfe (7) , normal 102 plasma FFA was maintained constant and muscle long-chain acyl-CoA levels did not 103 change, suggesting FFA availability, uptake, and cytosolic transport was not limiting. 104
Furthermore, restoring plasma FFA concentration during the exercise trial, via lipid 105 and heparin infusion, did not fully restore fat oxidation rates, again suggesting that the 106 inhibitory effect of increased carbohydrate availability resides at the level of 107 oxidation, rather than FFA availability (9) . In support of this theory, increasing fat 108 oxidation rates 2-fold during exercise at 65% VO2peak, due to different pre-exercise 109 muscle glycogen content, has no effect on muscle FFA uptake rates or FAT/CD36 110 (the protein responsible for FFA uptake into skeletal muscle) protein levels (6) . 111 112 5
A glance at CPT1 regulation during exercise 113
Several intracellular mechanisms leading to the down regulation of long-chain fatty 114 acid oxidation at the level of CPT1 during exercise with high glycolytic flux have 115 been proposed, including inhibition of CPT1 by malonyl-CoA, acylcarnitine, or 116 acidosis, and reduced substrate availability of carnitine or long-chain fatty acyl-CoA. 117
The following section will focus on mechanisms that have been investigated in vivo 118 and in humans. 119
120
Malonyl-CoA is a potent inhibitor of CPT1 activity in vitro and is a likely candidate 121 as the intracellular regulator of the rate of long-chain fatty acid oxidation human 122 skeletal muscle. Indeed, in resting human skeletal muscle, changes in malonyl-CoA 123 concentration have occurred with opposite changes in fat oxidation (10, 11) . Skeletal 124 muscle malonyl-CoA concentration is regulated by AMP-activated protein kinase 125 (AMPK) and by the cytosolic concentration of citrate, which inactivate and activate 126 the enzyme responsible for malonyl-CoA synthesis from acetyl-CoA (acetyl-CoA 127 carboxylase; ACC), respectively (12) . Thus, increased muscle concentrations of acetyl-128
CoA and citrate, due to increased glycolytic flux, would increase muscle malonyl-129
CoA concentration (via an increase in ACC activity) and, therefore, inhibit long-chain 130 fatty acid oxidation via CPT1. In support of this theory, a significant negative 131 correlation was obtained between muscle malonyl-CoA content and fat oxidation 132 rates in healthy middle-aged men during a two-step euglycaemic-hyperinsulinaemic 133 clamp (10) . Furthermore, hyperglycaemia with hyperinsulinaemia increased resting 134 skeletal muscle malonyl-CoA content 3-fold in healthy humans, resulting in a 135 functional decrease in CPT1 activity, as evidenced by an 80% inhibition of leg 136 (6) demonstrated that, despite a 122% 139 increase in fat oxidation rates (due to depleted pre-exercise muscle glycogen content) 140 during exercise at 65% VO2peak, there were no differences in muscle malonyl-CoA 141 content compared to control. These findings are also supported by other human 142 exercise studies where no association between malonyl-CoA content and fat oxidation 143 rates were obtained in skeletal muscle during prolonged moderate-intensity 144 exercise (13) or during graded-intensity exercise (14, 15) . Furthermore, a2-AMPK activity6 more than doubled with an associated 6-fold increase in ACCb (muscle isoform) 146 phosphorylation and significant decrease in malonyl-CoA concentration following 147 both prolonged and high intensity exercise, where fat oxidation paradoxically 148 increased and decreased, respectively (6, 15) . Taken together, these findings would 149 suggest that malonyl-CoA does not play a major role in the regulation of long-chain 150 fatty acid oxidation in human skeletal muscle during exercise. 151
152
Carnitine is the principal substrate for CPT1, suggesting that it may play a role in the 153 regulation of fat oxidation. Irving Fritz and colleagues first established that 154 mitochondria in a variety of tissues are impermeable to fatty acyl-CoA, but not to 155 fatty acylcarnitine, and that carnitine and CPT1 are essential for the translocation of 156 long-chain fatty acids into skeletal muscle mitochondria for b-oxidation (16) . Since 157 these discoveries it has been established that CPT1, situated within the outer 158 mitochondrial membrane, catalyses the reversible esterification of carnitine with long-159 chain acyl-CoA to form long-chain acylcarnitine. Cytosolic acylcarnitine is then 160 transported into the mitochondrial matrix in a simultaneous 1:1 exchange with 161 intramitochondrial free carnitine via the carnitine acylcarnitine translocase (CACT), 162 which is situated within the mitochondrial inner membrane (Figure 1 ). Once inside 163 the mitochondrial matrix, acylcarnitine is transesterified back to free carnitine and 164 long-chain acyl-CoA in a reaction catalysed by carnitine palmitoyltransferase 2 165 (CPT2), which is situated on the matrix side of the inner mitochondrial membrane. 166
The intramitochondrial long-chain acyl-CoA is then oxidised and cleaved by the b-167 oxidation pathway (17) . The significance of this "carnitine cycle" to fat oxidation 168 during exercise is highlighted in patients with carnitine, CPT2, or CACT deficiency 169
(CPT1 deficiency appears to be incompatible with life) who typically experience 170 severely reduced rates of fat oxidation during prolonged exercise along with muscle 171 pain and weakness, hypoglycaemia, and hypoketosis. CPT1 is considered to be the 172 rate-limiting enzyme for long-chain fatty acid entry into the mitochondria and 173 oxidation, but carnitine is classically not thought to be rate limiting to CPT1. Indeed, 174 the concentration of carnitine in skeletal muscle is around 5 mM intracellular water (18) 175 and far in excess of the in vitro Michaelis-Menten constant (Km) of muscle CPT1 for 176
carnitine of approximately 0.5 mM (19) . However, the enzymes of the carnitine cycle 177 co-immunoprecipitate and are mainly located in the specialised contact sites between7 outer-and inner-mitochondrial membranes in order to allow metabolic channelling (20) . 179
Thus, it is likely that the intramitochondrial content of free carnitine determines 180 carnitine availability to CPT1 and, as this is around 10% of the whole muscle 181 carnitine pool (21) , that in vivo carnitine availability could be rate limiting to the CPT1 182 reaction. Indeed, during conditions of high glycolytic flux, such as during exercise at 183 a high intensity or with elevated carbohydrate availability, muscle free carnitine 184 availability is reduced (2, 6) . 185
186

Free carnitine availability is reduced during high intensity exercise 187
The reduction in free carnitine availability observed with high glycolytic flux first 188 became apparent in 1966 when Childress and colleagues recognised that the blowfly 189 flight muscle, which does not oxidise fatty acids during flight, was rich in carnitine 190 and carnitine acetyltransferase (CAT) (22) . During the initial phase of flight, acetyl-191
CoA from glycolysis was generated faster than its utilisation by the TCA cycle, with a 192 However, this did not warrant their conclusion "this observation is consistent with the 215 premise that during intense exercise CAT catalyzes net flux in the direction of acetyl-216
CoA", which is certainly not consistent with the aforementioned studies in humans 217 that observed a net accumulation of acetlycarnitine during intense exercise. 218
219
Research by van Loon et al (2) demonstrated that a 35% decrease in the rate of long-220 chain fatty oxidation that occurred at an exercise intensity above 70% VO2max, 221 measured using a [U-
13 C]palmitate tracer, was paralleled by a 65% decrease in 222 skeletal muscle free carnitine content. In support of these findings, Roepstorff et al (6) 223 demonstrated a 2.5-fold decrease in the rate of fat oxidation, compared to control, 224 during moderate intensity exercise (65% VO2max) when free carnitine availability 225 was reduced to 50% (12 mmol×(kg dm) -1 ) of the total carnitine store, as a result of 226 pyruvate, and thereby acetyl-CoA, production being increased due to elevated pre-227 exercise muscle glycogen stores. Also, during bicycle exercise at 75% VO2max to 228 exhaustion, both muscle free carnitine content and fat oxidation rates were markedly 229 higher with low pre-exercise muscle glycogen content compared to control (32) . Taken 230 together, the above studies suggest a relationship between skeletal muscle free 231 carnitine availability (and therefore carbohydrate metabolism) and the regulation of 232 long-chain fatty acid oxidation rates, via CPT1, in human skeletal muscle during 233
exercise. 234 235
Is reduced free carnitine availability related to insulin resistance? 236
It would be remiss not to mention a recent growing body of research in the area of 237 skeletal muscle carnitine metabolism, particularly related to skeletal muscle insulin 238 resistance. Insulin resistance is characterized by a 'metabolic inflexibility' in the 239 reciprocal relationship between fatty acid and glucose oxidation within skeletal 240 muscle (33) . In keeping with observation in the same incomplete CAT knockout model 241
by Muoio et al (34) , a recent article of Lindboom and colleagues (35) asserts that "the 242 transformation of excessive acetyl-CoA into acetylcarnitine is important to maintain 243 metabolic flexibility", and that "compromised capacity to generate acetylcarnitine, 244 either due to reduced CAT activity or low carnitine concentration, may reduce 245 pyruvate dehydrogenase (PDH) activity, hence reducing oxidative degradation of 246 glucose". Contrary to this opinion, biochemically determined human muscle 247 acetylcarnitine content is reduced under insulin-stimulated, high glucose 248 conditions (36) , and increased in the insulin resistant state (37, 38) . What's more, as 249 mentioned above, compelling evidence has demonstrated a positive, constant linear 250 relationship exists between muscle acetyl-CoA formation and acetylcarnitine 251 accumulation over low to maximum rates of mitochondrial flux (22, 24, 27, 39) . 252
Lindeboom et al (35) themselves report maximal ex vivo CAT activity in participants 253 with type 2 diabetes (T2D) of 52.6 nmol/mg protein/min, which is far in excess of 254 PDC flux rates even during high intensity exercise (15 nmol/mg protein/min) (27) . This 255 clearly demonstrates that CAT is not limiting the equilibrium between acetyl-CoA 256 and acetylcarnitine, making it highly unlikely that acetylcarnitine accumulation could 257 be compromised for reasons other than rates of acetyl-CoA formation from PDH or β-258 Lindboom et al (35) would be dissipated if corrected for mitochondrial content, 265 particularly given the apparent impairment of muscle mitochondrial function in 266 patients with T2D is accounted for by differences in mitochondrial content (40) . Finally, 267 the resting muscle acetylcarnitine content of participants with T2D in Lindboom et al. 268
was 12% of the measured total carnitine pool, suggesting that free carnitine was 88% 269 of the total muscle carnitine pool and making it highly improbable that free carnitine 270 availability was limiting to PDH flux and acetylcarnitine formation. 271
272
Can skeletal muscle carnitine content be increased? 273
Further insight into whether free carnitine availability is limiting to CPT1 and the rate 274 of fatty acid oxidation can be provided by increasing skeletal muscle carnitine 275 content. However, the majority of the pertinent studies in healthy humans to date have 276 failed to increase skeletal muscle carnitine content via oral or intravenous L-carnitine 277 administration (39) . For example, neither feeding L-carnitine daily for up 3 months (41) , 278 nor intravenously infusing L-carnitine for up to 5 hours (42) , had an effect on muscle 279 total carnitine content, or indeed net uptake of carnitine across the leg (43) or arm (44) 280 (Table 1) . Furthermore, feeding 2-5 g×d -1 of L-carnitine for 1 week to 3 months prior 281 to a bout of exercise, had no effect on perceived exertion, exercise performance, 282
VO2max, or markers of muscle substrate metabolism such as RER, VO2, blood 283 lactate, leg FFA turnover, and post exercise muscle glycogen content (39) 
conditions, and so it is unlikely that simply increasing plasma carnitine availability 289 per se will increase muscle carnitine transport and storage (39) . Indeed, recent human 290 and porcine studies of arterio-venous carnitine fluxes confirmed that net muscle 291 carnitine uptake/efflux is negligible under fasting conditions (44, 45) , with systemic 292 concentrations of carnitine and acylcarnitines largely governed by gut absorption, 293 hepatic release and renal filtration (45) . However, insulin appears to stimulate skeletal 294 muscle carnitine transport, and intravenously infusing L-carnitine in the presence of 295 high circulating insulin (>50 mU×l -1 ) can increase muscle carnitine content by 296 15% (36, 42, 46) . Furthermore, ingesting relatively large quantities of carbohydrate in a 297 beverage (>80 g) can stimulate insulin release to a sufficient degree to increase whole 298 body carnitine retention when combined with 3 g of carnitine feeding and, if 299 continued for up to 6 months (80 g carbohydrate + 1.36 g L-carnitine twice daily) can 300 increase the muscle store by 20% compared to carbohydrate feeding alone (47) . Indeed, 301 ingesting 80 g of carbohydrate facilitated a positive net arterio-venous carnitine 302 balance across the forearm (44) which, assuming the majority of the measured plasma 303 carnitine extraction across the forearm occurred into skeletal muscle, equated to a 304 whole body muscle accumulation of 390 µmol and aligned well with the 370 µmol 305 (60 mg) carnitine retention predicted from differences in urinary carnitine excretion in 306 previous studies (48) . Extended to a chronic feeding scenario, this would equate to a 307 daily increase in muscle carnitine content of 50 µmol×(kg dm) -1 , which would 308 augment muscle total carnitine content stores (~20 mmol×(kg dm) -1 ) by 22% over 12 309 weeks. Again, this extrapolation is in good agreement with the 21% increase in 310 muscle carnitine content reported by Stephens et al (49) . However, such a large 311 11 carbohydrate load per se (160 g×d -1 ) will likely affect metabolism and alter body 312 composition (49) and so investigation into alternative oral insulinogenic formulations 313 that can stimulate muscle carnitine accumulation using lower carbohydrate loads is 314 warranted. For example, whey protein has previously been fed with carbohydrate to 315 promote insulin-mediated muscle creatine retention (50) and, unlike carbohydrate, 316 prolonged protein supplementation is less likely to influence body fat content (51) . 317
Unpublished data from our lab would suggest that daily feeding of 3 g of L-carnitine 318 in combination with a beverage containing 44 g of carbohydrate and 13 g of protein 319
results in around a 20% increase in the muscle carnitine pool over 24 weeks (Chee et 320
al, unpublished results). 321 322
Insert Table 1 here 323 324
Does increasing muscle carnitine content reduce the inhibition of fat oxidation 325 during high intensity exercise? 326
Consistent with the hypothesis that free carnitine availability is limiting to CPT1 flux 327 and fat oxidation, the increase in muscle total carnitine content in the study of Wall et 328 al (47) equated to an 80% increase in free carnitine availability during 30 minutes of 329 exercise at 50% VO2max compared to control and resulted in a 55% reduction in 330 muscle glycogen utilisation. Furthermore, this was accompanied by a 30% reduction 331 in PDC activation status during exercise, suggesting that a carnitine mediated increase 332 in fat derived acetyl-CoA inhibited PDC and muscle carbohydrate oxidation. Put 333 another way, L-carnitine supplementation increased muscle free carnitine 334 concentration during exercise at 50% VO2max from 4.4 to 5.9 mmol×l -1 intracellular 335 water, equating to an intra-mitochondrial concentration of 0.44 and 0.59 mmol×l -1 , 336 which is below and above the Km of CPT1 for carnitine, respectively (19) . On the other 337 hand, during 30 min of exercise at 80% VO2max with increased muscle total carnitine 338 content the same apparent effects on fat oxidation were not observed (47) . In contrast, 339 there was greater PDC activation (40%) and flux (16% greater acetylcarnitine), 340 resulting in markedly reduced muscle lactate accumulation in the face of similar rates 341 of glycogenolysis compared to control. This suggested that free carnitine availability 342 was limiting to PDC flux during high intensity exercise and that increasing muscle 343 carnitine content resulted in a greater acetyl-CoA buffering capacity and better (52) . Whether these improvements in endurance performance are due to glycogen 350 sparing as a result of a carnitine mediated increase in fat oxidation, or the reduced 351 reliance on non-oxidative ATP production from carbohydrate oxidation (increase acetyl-group accumulation that is associated with a greatly accelerated rate of lactate 364 production (39, 53) . This increasing proportion of glycolytic flux that is directed towards 365 lactate formation is often cited as a key component in the development of fatigue 366 during very intense exercise (54) . Under these conditions it is unclear whether free 367 carnitine availability is limiting to PDC flux and mitochondrial ATP resynthesis, or 368 simply that TCA cycle flux and PDC flux (i.e. mitochondrial capacity) are maximal. 369 This is most evident during repeated bouts of very high intensity exercise, where 370 acetylcarnitine accumulation during the first bout of exercise prevents further acetyl 371 group buffering during subsequent bouts due to reduced free carnitine availability, 372 which results in an increased reliance on phosphocreatine degradation (indicative of a 373 declining contribution from mitochondrial ATP delivery) and ultimately fatigue (55) . 374
Thus, if carnitine availability is indeed limiting to PDC flux during intense, repeated-375 bout exercise, it is plausible that increasing skeletal muscle carnitine availability as 376 increased the capacity to buffer excess acetyl groups during a single 3 min bout of 381 high-intensity exercise at 100% VO2max (as evidenced by a reduced muscle 382 phosphocreatine degradation), it did not further influence skeletal muscle metabolism 383 during a repeated bout, nor improve training-induced changes in muscle metabolism, 384
VO2max, or work output over 24 weeks of HIIT (55) . This would suggest that either 385 acetylcarnitine formation, or PDC flux, is not limiting to mitochondrial ATP delivery 386 during repeated bouts of exercise of this duration and intensity, or that the adaptations 387 to HIIT outweighed any benefit of increasing free carnitine availability. Indeed, 388 following 24 weeks of HIIT non-mitochondrial ATP production and acetylcarnitine 389 accumulation during a second bout of exercise were blunted to such an extent that 390 they were lower than the pre-training first bout, suggesting a better matching of PDC 391 and TCA cycle flux during repeated bouts of exercise and a lower dependence on 392 mitochondrial acetyl-group buffering. 393 394
Conclusion 395
In conclusion, it appears that skeletal muscle carnitine availability influences fuel 396 selection during exercise. Carnitine availability appears limiting to the CPT1 reaction, 397 such that during high intensity exercise a carbohydrate flux mediated decline in free 398 carnitine is paralleled by a decline in the rate of fat oxidation. Indeed, nutritionally 399 increasing skeletal muscle carnitine content increases fat oxidation during low 400 intensity exercise. However, increasing carnitine availability during high intensity 401 exercise does not offset the decline in fat oxidation, but facilitates a better matching of 402 carbohydrate flux by buffering excess acetyl groups from the PDC reaction. This, the 403 long-held belief that carnitine supplementation can improve endurance performance 404 via augmenting its role in fat oxidation should be revised to place more emphasis on 405 the major role that carnitine plays in carbohydrate metabolism during exercise, 406 particularly as increasing muscle carnitine content can improve high intensity exercise 407 performance and most athletes compete at high exercise intensities. However, caution 408 should be taken as nutritionally increasing carnitine content appears to have little 409 effect during repeated bouts of exercise at very high intensities or adaptation to HIIT 410 training, likely because oxidative metabolism is already maximal. 
